Drugs / ASP6858
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02359032 | Jan 2015 → Jan 2016 | — | Astellas Pharma Europe B.V. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASP6858 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02359032 ↗ |
| Route | Oral | “Oral tablets” NCT02359032 ↗ |